Department News

Fox Chase Cancer Center News

2024

• Fox Chase Cancer Center Researchers Develop Pancreatic Cancer Model Using Human Cells
• Lewis Katz School of Medicine at Temple University, Fox Chase Cancer Center Researcher Lucia Borriello Elected to Board of Directors of the Metastasis Research Society
• Fox Chase’s Camille Ragin Engages National Leaders on Health Disparities at White House Forum
• Fox Chase Cancer Center’s Camille Ragin Awarded AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship
• Fox Chase Cancer Center Researchers Show Estrogen Metabolites Contribute to Development of Lung Cancer Among People Who Never Smoked
• Fox Chase Cancer Center Researchers Show Mutation Increases Susceptibility to Asbestos-Induced Malignant Mesothelioma
• Star Wars Against Cancer: Attacking the Clones — Novel Strategy Could Mean More Durable Treatment for Leukemia
• Fox Chase Cancer Center to Hold Fourth Annual Cancer Epigenetics Symposium
• Fox Chase Cancer Center Welcomes Yash Chhabra
• Lewis Katz School of Medicine, Fels Cancer Institute for Personalized Medicine, and Fox Chase Cancer Center Welcome Amina Abdul-Aziz
• Fox Chase Researcher Receives Grant to Explore How to Indirectly Target Signaling Protein in Pancreatic Cancer
• Patients With Lynch Syndrome Not Employing Aspirin to Reduce Risk of Colon Cancer

2023

• Fox Chase Cancer Center’s Edna “Eti” Cukierman Named to Newly Created Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research
• Fox Chase Cancer Center/Lewis Katz School of Medicine Researcher Erica Golemis Named Editor-in-Chief of Cancer and Metastasis Reviews
• Researcher at Lewis Katz School of Medicine at Temple University and Fox Chase Co-Authors Study That Explains Why PIM Inhibitors Fall Short in Clinical Trials
• Fox Chase Cancer Center’s Edna Cukierman Awarded American Cancer Society’s Wilmott Family Professorship in Pancreatic Cancer
• Study Discovers a Mechanism for Genetic Changes in Therapy-Induced Leukemia, Builds on Fox Chase History of Exploring Links Between Epigenetics, Genetics, and Cancer
• Fox Chase Researcher Receives Grant for Study of RNA, Telomerase and Implications for Disease
• Fox Chase Cancer Center Welcomes Yu “Sunny” Liu
• Researchers From Fels Cancer Institute for Personalized Medicine and Fox Chase Find that Simultaneous Blocking of Multiple DNA Repair Pathways is Key to Novel Leukemia Treatment
• Development of New Anti-Integrin Drugs for Cancer and Other Diseases
• Surprising Discovery on Telomerase Biogenesis Has Implications for Cancer, Degenerative Diseases
• Fox Chase Cancer Center’s Camille Ragin Elected Chair of AACR Minorities in Cancer Research Council
• Fox Chase Cancer Center’s Edna ‘Eti’ Cukierman Appointed Chair-Elect of the American Association for Cancer Research’s Tumor Microenvironment Working Group
• Study Finds Thyroid Drug ‘Normalizes’ Tumor Cells in Pediatric Brain Cancer
• Annual Symposium at Fox Chase’s Cancer Epigenetics Institute Presents Latest Research in the Field
• DNA Methylation Makes Cancer Cells More Vulnerable to Immune Response, Fox Chase Cancer Center Study Shows
• Fox Chase Cancer Center’s Biosample Repository Facility Receives Accreditation From College of American Pathologists
• Study Shows How Leukemia Cells Repair Genetic Damage and Allow the Disease to Spread—and How to Stop Them Using Personalized Medicine
• New Drug Candidate Aims to Delay or Prevent Mesothelioma After Asbestos Exposure
• Fox Chase Cancer Center Welcomes Mitchell Fane